Cargando…

COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic

The recent corona virus disease (COVID-19) outbreak has claimed the lives of many around the world and highlighted an urgent need for experimental strategies to prevent, treat and eradicate the virus. COVID-19, an infectious disease caused by a novel corona virus and no approved specific treatment i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhavana, Valamla, Thakor, Pradip, Singh, Shashi Bala, Mehra, Neelesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443335/
https://www.ncbi.nlm.nih.gov/pubmed/32846164
http://dx.doi.org/10.1016/j.lfs.2020.118336
_version_ 1783573614943010816
author Bhavana, Valamla
Thakor, Pradip
Singh, Shashi Bala
Mehra, Neelesh Kumar
author_facet Bhavana, Valamla
Thakor, Pradip
Singh, Shashi Bala
Mehra, Neelesh Kumar
author_sort Bhavana, Valamla
collection PubMed
description The recent corona virus disease (COVID-19) outbreak has claimed the lives of many around the world and highlighted an urgent need for experimental strategies to prevent, treat and eradicate the virus. COVID-19, an infectious disease caused by a novel corona virus and no approved specific treatment is available yet. A vast number of promising antiviral treatments involving nanotechnology are currently under investigation to aid in the development of COVID-19 drug delivery. The prospective treatment options integrating the ever-expanding field of nanotechnology have been compiled, with the objective to show that these can be potentially developed for COVID-19 treatment. This review summarized the current state of knowledge, research priorities regarding the pandemic and post COVID-19. We also focus on the possible nanotechnology approaches that have proven to be successful against other viruses and the research agenda to combat COVID-19.
format Online
Article
Text
id pubmed-7443335
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74433352020-08-24 COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic Bhavana, Valamla Thakor, Pradip Singh, Shashi Bala Mehra, Neelesh Kumar Life Sci Article The recent corona virus disease (COVID-19) outbreak has claimed the lives of many around the world and highlighted an urgent need for experimental strategies to prevent, treat and eradicate the virus. COVID-19, an infectious disease caused by a novel corona virus and no approved specific treatment is available yet. A vast number of promising antiviral treatments involving nanotechnology are currently under investigation to aid in the development of COVID-19 drug delivery. The prospective treatment options integrating the ever-expanding field of nanotechnology have been compiled, with the objective to show that these can be potentially developed for COVID-19 treatment. This review summarized the current state of knowledge, research priorities regarding the pandemic and post COVID-19. We also focus on the possible nanotechnology approaches that have proven to be successful against other viruses and the research agenda to combat COVID-19. Elsevier Inc. 2020-11-15 2020-08-23 /pmc/articles/PMC7443335/ /pubmed/32846164 http://dx.doi.org/10.1016/j.lfs.2020.118336 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bhavana, Valamla
Thakor, Pradip
Singh, Shashi Bala
Mehra, Neelesh Kumar
COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
title COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
title_full COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
title_fullStr COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
title_full_unstemmed COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
title_short COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic
title_sort covid-19: pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the sars-cov2 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443335/
https://www.ncbi.nlm.nih.gov/pubmed/32846164
http://dx.doi.org/10.1016/j.lfs.2020.118336
work_keys_str_mv AT bhavanavalamla covid19pathophysiologytreatmentoptionsnanotechnologyapproachesandresearchagendatocombatingthesarscov2pandemic
AT thakorpradip covid19pathophysiologytreatmentoptionsnanotechnologyapproachesandresearchagendatocombatingthesarscov2pandemic
AT singhshashibala covid19pathophysiologytreatmentoptionsnanotechnologyapproachesandresearchagendatocombatingthesarscov2pandemic
AT mehraneeleshkumar covid19pathophysiologytreatmentoptionsnanotechnologyapproachesandresearchagendatocombatingthesarscov2pandemic